Schumacher Looks To Steer Tubulis To The Top Of The ADC Tree
CEO Relates Passion For Surrounding Himself With – And Advancing – Innovation
It has been quite a year for German biotech Tubulis, and CEO Dominik Schumacher tells In Vivo that the group has the potential to be “a really meaningful, sizable leader” in the antibody-drug conjugate space.
